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Abstract
One of the central goals of developmental neurobiology is to describe and understand the multi-tiered molecular events
that control the progression of a fertilized egg to a terminally differentiated neuron. In the nematode Caenorhabditis
elegans, the progression from egg to terminally differentiated neuron has been visually traced by lineage analysis. For
example, the two gustatory neurons ASEL and ASER, a bilaterally symmetric neuron pair that is functionally lateralized, are
generated from a fertilized egg through an invariant sequence of 11 cellular cleavages that occur stereotypically along
specific cleavage planes. Molecular events that occur along this developmental pathway are only superficially understood.
We take here an unbiased, genome-wide approach to identify genes that may act at any stage to ensure the correct
differentiation of ASEL. Screening a genome-wide RNAi library that knocks-down 18,179 genes (94% of the genome), we
identified 245 genes that affect the development of the ASEL neuron, such that the neuron is either not generated, its fate is
converted to that of another cell, or cells from other lineage branches now adopt ASEL fate. We analyze in detail two factors
that we identify from this screen: (1) the proneural gene hlh-14, which we find to be bilaterally expressed in the ASEL/R
lineages despite their asymmetric lineage origins and which we find is required to generate neurons from several lineage
branches including the ASE neurons, and (2) the COMPASS histone methyltransferase complex, which we find to be a critical
embryonic inducer of ASEL/R asymmetry, acting upstream of the previously identified miRNA lsy-6. Our study represents the
first comprehensive, genome-wide analysis of a single neuronal cell fate decision. The results of this analysis provide a
starting point for future studies that will eventually lead to a more complete understanding of how individual neuronal cell
types are generated from a single-cell embryo.
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Introduction
When establishing the nematode C.elegans as a genetic model
system, Sydney Brenner’s stated goal was the identification of
genes required to build a nervous system [1,2]. Several decades of
investigation, mainly using the classic forward screening methods
established by Brenner [1], have indeed revealed genes that are
required to generate a diversity of individual neuron types [3]. Yet
our understanding of nervous system development still remains
spotty. The advent of RNAi technology in C.elegans has opened an
alternative path to classic forward analysis to study the genetic
bases of various processes [4,5]. However, this approach has not
been undertaken in C.elegans to comprehensively study neuronal
development and fate determination. In this paper we utilize the
RNAi approach to screen, at a genome-wide level, for factors
involved in all aspects of neuronal development.
We are using the ASE gustatory neuron class, composed of two
bilaterally symmetric neurons, ASEL and ASER, as a paradigm to
understand how neuronal fate is specified. Each neuron is
produced by two distinct descendants of the embryonic blastomere
AB (Figure 1; [6]) called ABa (generates ASEL) and ABp
(generates ASER). There is a progressive restriction in the types
of cells produced by the AB blastomere. The great-granddaughter
of AB, ABalp, still produces cells from two different germ layers
(meso- and ectoderm), while one of its daughters, ABalpp only
produces neurons and glia. ABalpp’s posterior daughter, ABalppp,
then becomes committed to only produce neurons, one of them
the left ASE neuron. Similar progressive restrictions of fate occur
along the ABp lineage that generates the right ASE neuron. Little
is known about genes that control these lineage restrictions. The
RNAi screen we present here has uncovered a basic helix-loop-
helix (bHLH) transcription factor, hlh-14, that we characterize in
detail in this study. We find hlh-14 to be crucial for the
specification of neurons that derive from several lineage branches,
including the ASE neurons.
Once a lineage is committed to only produce neurons
(ABalpppp for ASEL and ABpraaap for ASER), fates have to be
differentially segregated to generate distinct types of neurons. At
this stage, as well as at earlier stages, a binary Wnt-signaling system
operates to differentially segregate fates via the anterior-posterior
differential distribution of the transcriptional regulators pop-1 and
sys-1 [7]. These factors presumably interact with stage- and
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[7,8].
One intriguing aspect of neuronal lineage specification in C.
elegans is that even though many neurons in the nervous system
come as bilaterally symmetric pairs, the lineage of the individual
cells that make up a pair can be remarkably distinct [9]. In other
words, cells that have limited lineage relation can produce
remarkably similar neurons. The pair of ASE neurons falls into
this category. As stated above, the left ASE neuron derives from
ABa and the right neuron from ABp, which are asymmetrically
localized in the early embryo. However, 4 cell divisions later, at
the beginning of gastrulation, the ABa and ABp descendants that
generate ASEL and ASER (called ABalppp and ABpraaa), begin
to undergo left/right symmetric cleavage patterns to generate
ASEL and ASER (Figure 1B). During gastrulation the descendants
of these cells migrate into left/right bilaterally symmetric positions
[10]. How this bilateralization process is regulated at the levels of
cell fate and cell morphogenesis is not known.
The correct specification of the ASE neurons involves not only
the imposition of ASE neuron identity that is shared by both the
left and the right ASE neuron, but also involves the retention of
the distinct lineage history of the two neurons. Even though
morphologically largely bilaterally symmetric, both ASE neurons
express a distinct set of chemosensory receptors and respond
differently to distinct sensory cues [11]. The differential, left/right
asymmetric expression of these receptors depends on a Notch-
mediated signal, received in the early embryo by the lineage that
produces ASEL (Figure 1B–1C; [12]). This Notch-mediated signal
results in a differential and transient expression of a pair of
paralogous T-box genes, tbx-37/38 [13], and then, several rounds
of cell division later, in the expression of the miRNA lsy-6 in the
ASEL, but not the ASER neuron [12]. How the information is
transmitted from Notch, via tbx-37/38,t olsy-6 restriction is not
known.
The lsy-6 miRNA has been uncovered through genetic screens
for mutants in which the expression of ASEL- and ASER-specific
chemoreceptors is disrupted [14]. These screens have uncovered
an important principle of ASEL/R laterality through the
identification of so-called Class I ‘‘2-ASEL’’ and Class II ‘‘2-
ASER’’ mutants [15]. In Class I mutants, both neurons adopt
ASEL fate (as assessed by expression of ASEL-specific gcy
chemoreceptors), while losing ASER fate; in Class II mutants
the opposite happens in that both neurons adopt ASER fate and
lose ASEL fate [16]. The molecular basis for this bistability is a
double-negative feedback loop of transcription factors and at least
one miRNA, the above-mentioned lsy-6 miRNA (Figure 1C;
[16,17]). Through genetic epistasis analysis, we have found the
earliest trigger of asymmetry to be the expression of the lsy-6
miRNA [16]. Yet, it is not known how its expression is restricted to
ASEL. Our screen has uncovered a novel regulator of ASE
asymmetry, the chromatin methlytransferase complex COM-
PASS. Through analysis of known and novel mutants in
components of this complex we show that the COMPASS
complex acts during embryogenesis, before the birth of the ASE
neurons, to regulate lsy-6 expression. As such, it provides a
potential molecular link between the early Notch-signal, tbx-37/38
expression and ASEL-specific lsy-6 expression in the maturing
ASE neurons.
Taken together, studying the development of the ASE neurons
provides a window to understanding a host of questions relevant to
neuronal differentiation – how are early lineage decisions made,
how are symmetry and asymmetry imposed, how are individual
neuronal cell fate decisions controlled? Previous genetic mutant
screens that used ASE differentiation markers as a read-out have
begun to address these questions, but these genetic screens have
not yet been saturated [18]. We sought to further expand the list of
genes required to build an ASE neuron. To facilitate the recovery
of lethal genes and to avoid the problem of mutational hotspots,
we have used a genome-wide RNAi screen to reach this goal. To
our knowledge, this is the first genome-wide RNAi analysis of a
single neuron cell fate decision.
Results
Establishing conditions for a genome-wide neuronal
RNAi screen
RNAi is known to work less efficiently in the nervous system
than in other tissues [19]. Indeed, we find that dsRNA directed
against gfp barely reduces gfp expression levels in transgenic
animals that drive a gfp reporter in the ASEL neuron (Figure 2A).
Several genetic backgrounds have been described in which
animals are more sensitive to RNAi. We tested three of these
backgrounds, nre-1 lin-15b [20], eri-1; lin-15b [21] and rrf-3 [22].
We find that in all of them ASE-specific gfp expression is now
significantly reduced, with nre-1 lin-15b and eri-1; lin-15b mutants
allowing more effective gfp knockdown than rrf-3 (Figure 2A).
Previous mutant analysis from our lab has identified a number
of genes required for the correct terminal differentiation of the
ASE neuron (Figure 2A–2B; [18]). We tested whether RNAi
recapitulates the mutant phenotype of 11 of these genes. We find
that in a non-sensitized background, RNAi of only 3 of the genes
partially recapitulates the mutant phenotype. In rrf-3 mutants, the
effects of knockdown improved for only some genes, but in both
nre-1 lin-15b and eri-1; lin-15b mutants, RNAi phenocopies the
effect of the respective mutant in most cases examined (Figure 2A–
2B). Since eri-; lin-15b mutants generally seem less healthy than nre-
1 lin-15b mutants, we chose the latter strain for our genome-wide
screen.
As the nre-1 lin-15b mutant background is relatively untested for
its overall sensitivity to RNAi in general, we screened all RNAi
clones on chromosome I not just for ASE neuronal phenotypes (as
we did for all chromosomes), but also for obviously visible
phenotypes, (sterility, embryonic or larval lethality, slow post-
embryonic growth, or post-embryonic morphological defects; see
Author Summary
The generation of a neuron from a fertilized egg requires a
multi-step cascade of molecules acting from within and
outside that cell to direct it towards a neuronal fate, rather
than, say, a muscle cell. These cascades are not fully
understood. In this study we systematically eliminate the
function of almost all genes in the C. elegans genome, one
by one, to determine what it takes to build a neuron. We
identified 245 genes that affect the development of a
specific sensory neuron pair, e.g. the neurons were not
generated or the neurons were generated but the terminal
fate was not correctly specified. We characterize in more
detail the transcription factor hlh-14, which we find is
required to generate multiple neurons, and the COMPASS
histone methyltransferase complex, which we find to have
a surprisingly specific role in the specification of a
molecular and functional left-right asymmetry in this
sensory neuron pair. Our study represents the first
genome-wide analysis of a single neuronal cell fate
decision. Further characterization of the genes identified
here will enhance our understanding, and thus our
capacity for treatment and prevention, of human neuro-
logical disorders.
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PLoS Genetics | www.plosgenetics.org 2 June 2011 | Volume 7 | Issue 6 | e1002109Figure 1. The embryonic origins and specification of the ASE neurons. A: The early lineage of the C. elegans embryo leading to the
formation of the five founder blastomeres (AB, MS, E, C and P3). The pie-charts indicate the relative number of cells and tissue types that are produced
from each founder blastomere. The majority of neurons, including ASE, descend form the AB blastomere. B: Lineage of the ASEL and ASER neurons
indicating they descend from asymmetric lineage origins which first diverge at the AB
2-cell stage (adapted from [6]). The Notch signal that specifies
the difference between ABa and ABp blastomeres is indicated and leads to the down-regulation of tbx-37/tbx-38 (expression indicated in green) in
the ABp lineage. This early lineage difference is crucial for the specification of ASE left-right asymmetry [12]. The molecular link between the
expression of tbx-37/tbx-38 and the specification of ASE asymmetry is unclear. From the ABalpp/ABpraa stage onwards the lineage produces
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reported chromosome I screens of visible phenotypes, conducted
either in a wildtype or an rrf-3 mutant background (Figure 2C;
[22,23]). We found a total of 779 clones with at least one visible
phenotype detected, with an overlap of 82% and 88% for the rrf-3
and wildtype Bristol N2 screens respectively. When compared to
the group of clones for which phenotypes were reported in both
rrf-3 and wildtype N2 screens, our screen reveals 95% overlap.
When we specifically compared the phenotypic categories
reported by others and us, we found a striking trend of genes
being shifted into more severe phenotypic categories in the nre-1
lin-15b background. For example, of the 303 clones reported
previously to produce a Gro phenotype (slow growth), we found
57% to also be Gro in our screen but an additional 22% were
found in more severe non-viable categories (Figure S1).
A genome wide RNAi screen identifies 245 genes that
affect expression of an ASEL-specific neuronal fate
marker
Using the nre-1 lin-15b sensitized background and the ASEL-
marker lim-6::gfp (otIs114 transgene), we then went on to conduct a
primary screen of all available clones. We were able to screen
15,395 RNAi clones for ASEL defects, equaling 81% of genes in
the genome. In the primary screen, all clones were scored in
duplicate, revealing that 748 RNAi clones affect development of
the ASEL neuron, as evidenced by loss or ectopic expression of the
lim-6::gfp marker. These 748 clones were re-screened 6 additional
times and we set the arbitrary threshold of considering any clone
that repeated at least 3/8 times as positive. These criteria
identified a total of 245 genes that affect the development of the
ASEL neuron (Figure 3). Examples of some of the knockdown
phenotypes are shown in Figure 4 (showing either the RNAi
phenotype or mutant alleles that confirm the RNAi phenotype).
The vast majority of these genes (237/245) cause embryonic
lethality, in addition to the ASEL phenotype. Of these 245 genes,
21 genes resulted in ectopic expression of the ASEL marker and
210 genes resulted in a loss of ASEL marker expression when
knocked-down. 14 genes displayed a mixed phenotype, i.e.
individual animals within a population of treated animals show
either no phenotype, loss or ectopic expression of the ASEL
marker (this category was not further pursued; Table S1).
Early arrest. To determine whether loss of ASEL marker
expression was due to (a) a specific loss of ASEL, (b) a more broad
neuronal differentiation defect or (c) general early embryonic
arrest, we re-screened the 210 genes that resulted in a loss of ASEL
with fluorescently labeled differentiation markers for ectoderm,
mesoderm or endoderm. We used two neuronal markers that label
6 different classes (each class composed of a pair of symmetric
neurons) of dopaminergic and cholinergic neurons with limited
lineage relation (dat-1::rfp; ttx-3::rfp, both contained on one array), a
collagen marker for hypodermis (dpy-7::yfp), a myosin muscle
marker (myo-3::gfp) and a gut-specific GATA factor marker (elt-
2::gfp). We considered all those genes that by RNAi led to a loss of
all tissue markers tested as ‘‘early arrest’’ genes (87 genes; Table
S2). Additionally, we included in this list those genes that have
previously been characterized as arresting before the 200-cell stage
(11 genes; [24]) and those genes whose knock-down resulted in a
loss of all markers tested except the dopaminergic neuron marker,
as we presume this to result from non-reproducibility of RNAi (8
genes; we note that as expected, knock-down of these genes also
led to a loss of expression of an ASER marker and a bilateral ASE
marker). Finally, we also considered as early arrest those genes
whose knock-down led to a loss of neurons and muscle but not gut,
since the latter marker is expressed early in development before
terminal neuronal differentiation (31 genes). In this manner we
classified a total of 137 of those genes that led to a loss of lim-6::gfp
expression as ‘‘early arrest’’ genes (Figure 3 and Table S2). More
than 80% of genes in this category classify as genes involved in
metabolism, cell/organelle structure and basic cellular processes
like cell division.
Broad neuronal defects. Interestingly, we were also able to
identify from this tissue screen 21 genes that when knocked-down
by RNAi led to a broad loss of neurons (Figure 3 and Table 1). In
all cases, in addition to a loss of the ASEL marker, the
dopaminergic/cholinergic markers were absent, yet either
muscle, or muscle and gut, were unaffected. We note that in all
cases the expression of the hypodermal marker was absent, which
is consistent with a loss of all ectodermal tissue. Genes in this
category include two mex genes, known to be involved in
determining the identity of the AB blastomere (which produces
mainly ectodermal tissue), with their loss leading to excess P-cell
descendants such as muscle, being generated ectopically from the
AB-lineage (hence muscle excess for mex [25]; Table 1). We suspect
that other genes in this category are also involved in establishing
early blastomere asymmetry and identity. We examined these and
several other genes in this category in more detail by performing
RNAi in the background of a pan-neuronally expressed gene (rab-
3::yfp). While both mex-3 and mex-5 led to an almost complete loss
of neurons, no other gene examined generated such a complete
loss of neurons, suggesting they generate broad neuronal but not
pan-neuronal differentiation defects (Figure S2).
Neuron-type specific defects. We then re-screened the
remaining genes, that show specific ASEL defects (52 genes with a
loss of ASEL marker and 21 genes that showed ectopic ASEL
marker expression), with an ASER specific marker and an ASE
bilateral marker in order to distinguish between the following three
RNAi knock-down phenotypic categories: (1) genes that cause
ASE cell/lineage defects (loss or ectopic ASEL and/or ASER cells
– but not a complete loss of ASE cell fate); (2) genes that cause
bilateral loss of ASE cell fate; (3) genes that cause ASEL versus
ASER asymmetry defects. Firstly, we classified those genes that
showed ectopic expression of the ASEL marker in additional cells,
with the ASER marker being unaffected (or vice versa) as having
an ectopic ASEL (or ASER) lineage and we classified those genes
that showed a loss of the ASEL marker with the ASER being
unaffected (or vice versa) as having lost an ASEL (or ASER)
lineage. These genes may alter the fate of entire lineage branches
or they may cause individual cells to lose/acquire an ASE fate –
exclusively ectodermal tissue. From the ABalpppp/ABpraaap stage onwards the lineage produces exclusively neurons, including ASE. Purple asterisks
indicate the point at which the proneural gene hlh-14, described in this paper, acts to regulate neuronal differentiation in the ASE lineage. C:
Summary of the previously described bi-stable feedback loop that regulates ASE left-right asymmetry. The bi-stable feedback loop consists of both
transcription factors and micro-RNAs and controls the expression of downstream terminal differentiation genes. All factors in the loop and the
downstream terminal factors are regulated in addition by the ASE terminal selector che-1 (expression indicated in B in orange). The molecular link
between the early lineage difference and the bi-stable feedback loop is not known. Brown asterisks indicate that the COMPASS histone-modifying
complex, also identified in this paper, acts earlier than che-1 and before the birth of the ASE neurons to regulate lsy-6 expression and control ASE
asymmetry.
doi:10.1371/journal.pgen.1002109.g001
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PLoS Genetics | www.plosgenetics.org 4 June 2011 | Volume 7 | Issue 6 | e1002109Figure 2. Testing hypersensitive strains and validating the screen with visible phenotypes. A: Table indicating the quantification of the
laterality defects observed following RNAi knock-down of the indicated genes in wild-type (otIs114) and 3 different RNAi sensitized backgrounds. nre-
1(-) lin-15b(-) and eri-1(-); lin-15b are the most sensitive strains for ASE. In all cases n.40.
1Scored with otIs114;
2Scored with otIs186;
3Scored with
otIs299;
4ASE defect refers to loss or dimming of ASEL::gfp, ASER::gfp or ASE::gfp;
5ASE defect refers to ectopic expression of ASEL::gfp in ASER or loss or
dimming of ASER::gfp or ASE::gfp;
6ASE defect refers to loss or dimming of ASEL::gfp or ASE::gfp and ectopic expression of ASER::gfp in ASEL;
7ASE
defect refers to loss or strong dimming of ASEL::gfp, ASER::gfp or ASE::gfp;
8For fozi-1 ASE defect refers to ectopic expression of ASEL::gfp in ASER or
loss of ASER::gfp or ASE::gfp. For lim-6 it refers to loss of ASEL::gfp expression or ectopic expression of ASER::gfp in ASEL;
9ASEL::gfp when still present
appeared much dimmer than in any other strain;
106/6 escapers displayed ectopic expression of ASEL::gfp in ASER;
111/1 escaper displayed ectopic
expression of ASEL::gfp in ASER;
12Taken from Flowers and Poole et al. 2010. B: Representative pictures of the ASE laterality that result from RNAi
knock-down of the indicated known ASE factors in an nre-1(-) lin-15b(-) background. ASEL is labeled with lim-6
prom::gfp and ASER is labeled with gcy-
5
prom::gfp. L4440 refers to feeding with an empty RNAi vector. Examples of the 4 main classes of ASE phenotype as described in [18]. Class I is 2-ASEL,
class II is 2-ASER, class III is 0-ASE (loss of ASE cell fate) and class IV is mixed (in the case of fozi-1 ASEL markers are depressed in ASER but ASER
markers are unaffected). C: Comparison of the visible phenotypes observed in our screen with previous screens for all genes on Chr I. Ovals represent
the amount of bacterial clones that gave an RNAi phenotype in an experiment with results from our screen shaded in pink and previous published
results shaded in grey. Areas that overlap represent clones (in %) for which in both experiments an RNAi phenotype was detected. Differences and
overlap between an RNAi experiment done with the lin-15b nre-1 mutant strain and (in the following order): (1) all data previously reported for an
RNAi experiment on Chr. I (whether as part of a genome wide screen, subscreen or a single experiment, exported from wormbase.org WS190); (2) the
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identified 11 genes with ASE cell/lineage defects (Figure 3 and
Table 2). Nearly half of the genes that fall into this class are genes
that are previously described as affecting early blastomere
identities, including, for example, par genes [26].
Secondly, we classified those genes that result in a loss of both
the ASEL and the ASER cell fate markers, as loss of ASE fate (as
expected, knock-down of the majority of these genes also resulted
in no expression of a bilateral ASE marker). In addition, one gene,
although seemingly wildtype for the ASER marker did not express
a bilateral ASE marker and was added to this group. A total of 42
genes fell into this group (Figure 3 and Table 3). Note that, as
stated above, dopaminergic and cholinergic neuron markers are
unaffected by these genes. A majority of genes in this list have a
role in gene regulation, either on the DNA or RNA level. The list
includes a known regulator of ASE specification, the ASE terminal
selector che-1 [15,27], and the bHLH gene hlh-14 that we describe
in more detail later in this paper.
L/R asymmetry defects. Finally, we identified 20 genes,
knock-down of which caused an ASE asymmetry defect (Figure 3
and Table 4). We classified genes as having an asymmetry defect
when the bilateral ASE marker is unaffected but ectopic
expression of either the ASEL or ASER marker is observed. In
addition, 4 genes for which the result from the bilateral marker
was ambiguous, but which clearly showed loss of the ASEL marker
and expression of the ASER marker in one extra cell or vice versa
were added to this list. Ten genes showed ectopic expression of the
ASEL marker, in 2/10 the ASER marker was lost, indicating a
Class I (2-ASEL) phenotype, while in 7/10 the ASER is unaffected
indicating a Class IV (mixed) phenotype (see Figure 2B). 11 genes
showed a Class II (2-ASER) phenotype. This list includes a
number of previously described regulators of ASE laterality, such
as die-1, lsy-22, lsy-2, fozi-1 and lim-6 and, in addition, some novel
genes that we describe later on in this paper.
Taken together, our RNAi screen uncovered a rich set of genes
that affect early development, broad neuronal development,
lineage specification and terminal ASE differentiation. Function-
ally, genes fall into a variety of different categories, from signaling
to gene regulatory factors. In the second and third parts of this
paper we undertake a more in-depth analysis of two sets of genes
retrieved from our screen: (1) One specific transcription factor, the
bHLH transcription factor hlh-14; (2) several genes that code for
members of a specific histone-methylation complex, called
COMPASS.
The Achaete-Scute-like bHLH gene hlh-14 controls
neuronal fate induction
The RNAi screen identified the hlh-14 gene as affecting overall
differentiation of ASEL/R. hlh-14 RNAi animals are viable and
display a loss of asymmetrically expressed and bilaterally expressed
genes in ASE to varying extents (Table 5). We first set out to
corroborate the RNAi phenotype using available mutant alleles of
hlh-14. We found that two different alleles of hlh-14 recapitulated
the ASE differentiation phenotype observed upon RNAi and were
larval lethal as previously reported [28]. Asymmetrically expressed
genes are lost in hlh-14 mutants, as is the expression of che-1,a
terminal selector of ASE neuron differentiation (Figure 5A and
Table 5). The defects are almost completely penetrant in hlh-
14(tm295), a deletion allele that removes the entire bHLH domain
and is likely a functional null.
We find that other neurons that are lineally related to ASE are
also affected in hlh-14 mutants, as assessed by loss of terminal fate
marker expression of the OLL and AFD neuron pairs. These
broader neuronal defects were not apparent during initial RNAi
screening since the dopaminergic and cholinergic neuron marker
was unaffected and hlh-14(RNAi) animals are viable, unlike hlh-14
mutants which are larval lethal. Intriguingly, the effect on fate
appears to be more pronounced the more posterior a neuron is
located in the lineage (Figure 5A and Table 5).
We analyzed the hlh-14 mutant phenotype in more detail using
a classic lineaging approach, in which we monitored cell position,
cleavage and morphology, using 4D microscopy [10]. We find that
from the AB
64-cell stage onwards, during gastrulation, the
ABalpppp/ABpraaap neuroblasts and their descendants migrate
dorsally, towards a location usually populated by hypodermal cells
[6], rather than remaining more ventrally positioned as they do in
wild-type animals. By the AB
256-cell stage these descendants are
both dorsally and posteriorly mislocalised (Figure 5B). At this
stage, the time at which hypodermal cells normally cease division
and differentiate, these descendants fail to divide further, unlike
wild-type cells, which undergo one or two more rounds of division
before differentiating into neurons. Furthermore, in certain cases
where we were able to follow the cells for a sufficient period of
time, we observed that they acquired a hypodermal-like cell
morphology. We observe more frequent hypodermal transforma-
tions and mis-positioning defects in more posterior descendants of
the ABalpppp/ABpraaap neuroblasts (Figure 5B). Additionally, we
examined the hypodermal cell fate marker dpy-7 in hlh-14(tm295)
mutants at the comma stage (Figure S3). Although we were able to
easily observe additional cells in the posterior of the embryo,
consistent with previously reported cell fate transformations [28]
and novel tranformations that we describe below, we were unable
to unambiguously identify extra hypodermal cells in the anterior of
the embryo due to the dim expression of dpy-7 in certain anterior
hypodermal cells (we note that several anterior hypodermal cells,
in addition to the hypodermal seam cells, do not appear to express
dpy-7 at this stage). Nevertheless we were able to observe
mispositioned hypodermal cells in the anterior of the hlh-
14(tm295) mutants, where the transformed cells of the
ABalpppp/ABpraaap reside (Figure S3). The division and dorsal
mispositioning defects are more severe in the null allele of hlh-14
(Figure 5B). Together, these data are consistent with a neuron-to-
hypodermal transformation of these cells and suggest that, in
addition to cell fate, hlh-14 regulates aspects of cell migration.
To examine hlh-14 gene expression, we generated a YFP-tagged
hlh-14 transgene through fosmid recombineering (Figure 5C; [29]).
This fosmid reporter fully rescues the lethality, division, morpho-
genesis and ASE cell fate defects of hlh-14 mutants (Figure 5B and
Table 5). We find, using 4D-lineage analysis, that this reporter and
a previously published hlh-14 translational reporter [28] show
similar expression in the ASE lineage. hlh-14 is first expressed at
the AB
64-cell stage (Figure 5B). This is just shortly after the point at
which the ASE-lineages, which descend from distinct asymmetric
blastomeres, become symmetric in terms of division pattern and
daughter cell fates; the descendants will form exclusively neurons
and glia, producing the left-right bilateral homologs of eleven pairs
of neurons and two pairs of glia (Figure 1). It is also the time we
begin to see morphogenesis defects and together is consistent with
a role of hlh-14 being a bilateral binary switch at, or shortly after
data obtained by screen done with the hypersensitive rrf-3 strain [22]; (3) the data obtained by screen done with the standard laboratory strain Bristol
N2 [23]; (4) the data obtained by an overlap of phenotypes reported in both Simmer and Kamath screens.
doi:10.1371/journal.pgen.1002109.g002
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(Table 1, Table 2, Table 3, Table 4, and Tables S1 and S2) for the list of genes in each category, a more detailed phenotypic description and their
functional categorization.
doi:10.1371/journal.pgen.1002109.g003
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hypodermal fate.
hlh-14 expression appears to persist longer in posterior parts of
the ABalppp/praaa lineage than in anterior parts, thereby
mirroring the differential phenotypic severity of hlh-14 removal
(Figure 5A–5B). In the ASE branch, located at the posterior part of
the lineage, hlh-14 expression is maintained throughout the lineage
until shortly before the terminal division of the ASE neurons,
suggesting not only early neuronal versus hypodermal decision
roles for hlh-14 but perhaps also a later role in differentiation.
Consistent with such a notion we find that on examining ASEL,
partial removal of hlh-14, through RNAi in animals that express
two distinct markers for ASEL fate simultaneously, sometimes
leads to loss of one but not the other marker (13/28 embryos in
which ASEL was still present, as assessed by a lsy-6::yfp reporter,
lost ceh-36::mCherry expression) suggesting the ASE cell is still
produced but fails to differentiate correctly.
Symmetric and asymmetric expression of hlh-14 in other
neuronal lineages
In addition to its expression in the ASE lineage, we observe by 4D-
lineage analysis that our hlh-14 fosmid reporter is expressed in several
other neuronal lineages. In some instances this expression is
bilaterally symmetric, such as in the neuroblasts that give rise to the
L/R bilaterally symmetric PLM/ALN neuronal pairs, PVQ/HSN/
PHB neuron pairs and the ALM/BDU neuron pairs (Figure S4).
Surprisingly, in other instances this expression is L/R asymmetric,
such as in neuroblasts of the C lineage (Figure 6). We observe
asymmetric expression in two asymmetrically generated neuroblasts,
the Caapa neuroblast that gives rise to the DVC neuron and a cell
death, and the Caappv cell, which differentiates into the neuron
PVR. The bilateral homologs of these hlh-14-expressing neuroblasts
are non-neuronal hypodermal cells (Figure 6C). In both hlh-14(gm34)
and hlh-14(tm295) mutants we observe that the Caapa neuroblast
divides precociously, indicative of a hypodermal transformation. In
the position of Caapaa, we observe an ectopic cell expressing the dpy-
7 hypodermal cell marker, corroborating that PVR has been
transformed into hyp11, the normal fate of Caappv’s bilateral
homolog (Figure 6C). These division defects are rescued by the hlh-
14
FOS::yfp transgene (Figure 6C). Several other lineages in which we
observe hlh-14 expression also give rise mainly to hypodermal cells,
the P-cells in the case of the PLM/ALN and PVQ/HSN/PHB
lineages (Figure S4B) and the V-cells in the case of the ALM/BDU
lineage (Figure S4C). In the PVQ/HSN/PHB lineage we also
observe precocious division of the neuroblast that gives rise to these
neurons and ectopic dpy-7 expressing cells in the tail in the absence of
hlh-14 (Figure S3; data not shown). We suggest that hlh-14 acts as a
neural/hypodermal switch in the neuroblasts of all these lineages.
Intriguingly, we also observe expression in the bilaterally
symmetric neuroblasts that produce a pair of pharyngeal
interneurons known as I1L/I1R (Figure S5). The lineages that
generate these neurons are unusual for two reasons: (1) they derive
from L/R asymmetric origins and (2) they are multi-potent, giving
rise to mesodermal, epithelial and neuronal cells of the pharynx.
We find that in hlh-14(tm295) mutants the division of this
neuroblast is again premature, more closely matching the division
time of its sister, which does not express hlh-14 and normally gives
rise to two myoepithelial cells, a muscle and a marginal cell (Figure
S5B). While it is currently unclear what fate these cells acquire in
the absence of hlh-14, it suggests that in addition to regulating
neural/hypodermal fate decisions, hlh-14 regulates more general
neural/non-neural cell fate decisions and that ‘‘non-clonally’’
derived neurons use the same basic neural specification mecha-
nisms as clonally derived neurons.
Finally, we observe later expression of hlh-14 in currently
unidentified lineages, at a time in which all terminally differen-
tiated cells present at hatching are already formed. This is
consistent with hlh-14 acting during terminal cell fate decisions in
other lineages. Taken together, hlh-14 acts as a proneural gene to
regulate early neuroblast cell fate, morphogenesis and certain
aspects of terminal differentiation in multiple L/R symmetric and
L/R asymmetric neuronal lineages. In the ASE lineage, its
proneural activity is graded in an anterior-to-posterior manner.
The COMPASS histone methyltransferase complex
regulates ASE laterality
Our RNAi screen revealed ASE laterality defects upon
knockdown of two different components of the histone methyl-
transferase complex COMPASS [30], ash-2 (a PHD/SPRY
domain protein) and dpy-30. A third locus, F21H12.1, also
generated ASE laterality defects and we find that this locus
corresponds to the worm ortholog of an additional member of the
COMPASS complex, the WD40 protein RbBP5, here-on referred
to as rbbp-5 (Table 4 and Table S3; Figure 7). We confirmed the
ash-2(RNAi) and dpy-30(RNAi) ASE laterality defects observed
during our RNAi screen using mutant alleles of the respective
genes (Figure 7 and Table S3). In regard to rbbp-5, we noted that it
resides in the mapping interval of the previously identified but
uncloned lsy-15 gene, an ASE laterality mutant retrieved from a
large-scale mutagenesis screen [18]. As previously described, lsy-
Figure 4. Examples of phenotypic classes uncovered by the
screen. A: ASE cell/lineage defect—grp-1(tm1956) mutants, a GTP
exchange factor, display ASE lineage defects in embryonic and larval
stages. In the figure shown the animal has a total of 3 ASEs. One that
displays ASER fate (blue circle), and instead of one that displays ASEL
fate as seen in wild-type animals, grp-1(-) animals display two ASEL
fated cells (red circles), suggesting an ectopic ASEL lineage has formed
in these mutants. B: ASE asymmetry defects—Panel on the left shows
RNAi knockdown of gene S-adenosylmethionine synthetase (sams-3)
results in a class I ‘‘2-ASEL’’ phenotype in which ASER (blue circle) looses
its sub-type specific fate and transforms to ASEL (red circle). Overall ASE
fate is unaffected. We observed a similar phenotype with similar
penetrance for sams-4 (data not shown). Panel on the right shows the
phenotype of histone deacetylase hda-1(ok1595) mutants which display
a class II ‘‘2-ASER’’ defect. ASEL fate is reported by lim-6
prom::gfp
expression, ASER fate is reported by gcy-5
prom::gfp or gcy-5
prom::mCherry
and ASE fate is reported by 8XASE::gfp. *Indicates expression unrelated
to the ASE neurons.
doi:10.1371/journal.pgen.1002109.g004
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this phenotype, like those of the other COMPASS members, is
maternally rescued (see below). Additionally, lsy-15(ot86) mutants,
like other COMPASS complex mutants, display a partially
penetrant dumpy phenotype, a low brood size and an egg-laying
defect (data not shown). The latter is likely the result of a uterine
Table 1. Genes that elicit broad neuronal defects when knocked-down by RNAi.
Gene Name
Functional
Category Domain/Function ASEL Neurons Muscle Gut Hyp ASER ASE
tbg-1 cell/organelle Tubulin - - + -
his-42 chromosome Histone H3 - - ++ -
zyg-9 chromosome Microtubule-associated protein - - ++ -
R04F11.3 chromosome DNA polymerase subunit Cdc27 - - ++ ne
R53.6 chromosome DNA replication (GINS complex subunit) - - ++ -
his-3 chromosome Histone H2A - - ++ -
csc-1 chromosome Subunit of the Aurora B kinase complex - - ++ -- -
his-13 chromosome Histone H3 - - ++ -
his-4 chromosome Histone 2B - - + --
pole-2 chromosome DNA polymerase epsilon, subunit B - - + --
ran-3 chromosome Spindle formation (RCC repeat) - - + --
gpr-1 blastomere G protein regulator (GoLoco motif) - - ++ -
mex-3 blastomere RNA binding KH domain - - ++ -- n e
mex-5 blastomere RNA binding CCCH domain - - ++ -
gpr-2 blastomere G protein regulator (GoLoco motif) - - + --
T01H3.4 novel Transmembrane domains - - ++ -
C30B5.4 RNA reg. RNA binding RRM domain - - + --
T09A5.9 signalling Regulatory subunit protein phosphatase 1 - - ++ -
F19F10.9 splicing SART-1 family (U4/U6.U5 snRNP associated
protein)
-- ++ -
M03C11.7 splicing Pre-mRNA processing factor 3 - - + -
D1054.14 splicing PRP38-like splicing factor - - + --
See Materials and Methods for a detailed description of scoring criteria. Abbreviations: ne, not embryonic lethal.
doi:10.1371/journal.pgen.1002109.t001
Table 2. Genes that elicit ASE cell/lineage defects when knocked-down by RNAi.
Gene Name
Functional
Category Domain/Function ASEL .2 ASEL ASER .2 ASER ASE
.2
ASE Viable
ASE lineage
phenotype
Mutant
phenotype
lis-1 cell/organelle WD40 - wt +/2 Loss ASEL
lrg-1 chromosome let-99 related (pseudogene) ++ /2 ++ ectopic ASEL
1
par-3 blastomere PDZ domain ++ + + + ectopic ASEL
1
mei-2 blastomere Microtubule regulator (similar
to katanin)
+ - +/2 + ectopic ASEL
2
par-2 blastomere RING finger ++ - ne ectopic ASEL
2 Yes
lit-1 blastomere Serine/threonine kinase (Wnt
signalling)
- ++ + + ectopic ASER
pie-1 blastomere Zinc finger, CCCH-type ++ - ++ ectopic ASEL
2
ced-3 signalling Caspase ++ + + + Yes ectopic ASEL
1 Yes
oac-35 signalling Integral membrane O-
acyltransferase
++ - ne ectopic ASEL
2
wwp-1 signalling E3 ubiquitin ligase ++ + + /2 + ectopic ASEL
1
ref-1 transcription bHLH + wt ++Yes ectopic ASEL Yes
See Materials and Methods for a detailed description of scoring criteria. Abbreviations: ne, not embryonic lethal; wt, wildtype.
1also ectopic ASER lineage.
2also loss of ASER lineage.
doi:10.1371/journal.pgen.1002109.t002
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Gene Name
Functional
Category Domain/Function ASEL Neurons Muscle Gut Hyp ASER ASE Viable
Mutant
phenotype
hda-1 chromatin Histone deacetylase - + - + - - - Yes
cdk-7 chromosome Cyclin-dependent Kinase - ++ --- -
cdk-9 chromosome Cyclin-dependent Kinase - ++ + -- -
csnk-1 chromosome Casein Kinase - ne + ne + --
F09D1.1 chromosome Ubiquitin hydrolase - + - + -- -
him-10 chromosome Nuf2 kinetochore homolog - + - + -- +/2
rfc-1 chromosome Replication factor C - - + -- n e
rpb-8 chromosome RNA polymerase subunit 8 - ++ --- -
spdl-1 chromosome Coiled coil protein required
for chrom segregation
- ++ + + -n e
sur-6 chromosome Protein phosphatase 2A,
regulatory subunit
- + - + -- +/2
aph-1 blastomere Transmembrane protein
req. for Notch signaling
- ++ + + -n e
par-6 blastomere PDZ domain - ++ --- +/2
glp-1 blastomere Notch - ++ + - - - Yes
pfd-6 metabolism Prefoldin - - + -- +/2
rnf-113 metabolism Hydrolase (HAD) and RING finger - ++ + - - - Yes
mel-32 metabolism Serine hydroxymethyltransferase
(Ser-.Gly)
-- + - + -w t
ccdc-55 novel Conserved coiled-coil - ++ + -- -
F37C12.1 novel Conserved coiled-coil - ++ --- -
mog-4 RNA reg. DEAH helicase - ++ + - - ne No
1
mog-5 RNA reg. DEAH helicase - ne + --- - N o
1
rnp-6 RNA reg. RNA-binding RRM domain - ++ + -- +/2
mag-1 RNA reg. MAGonashi homolog - ++ + -- w t N o
1
D1043.1 splicing INTS7 homolog; Integrator
complex component
- + -- - +/2 +/2
F23F1.5 splicing Snurportin - ++ + + - +/2
K07C5.6 splicing Pre-mRNA splicing Prp180-interacting - ++ --- -
nxt-1 splicing RNA export factor - + -n e
ZC376.6 splicing Integrator subunit - ++ + -- +/2
Y65B4A.6 splicing Tsl. Initiation factor
(DEAD/DEAH helicase)
- + -w t
che-1 transcription ZF - C2H2 - 4 - ++ + + - - Yes Yes
F28B3.1 transcription Disco (C2H2) -interacting protein
AMP-binding
-n e + - - - ne No
1
hlh-14 transcription bHLH - ++ + - - Yes Yes
let-49 transcription Mediator complex - - ne No
1
mdt-17 transcription Mediator complex - + wt -
pqn-38 transcription Mediator complex - ++ + -- - N o
1
sel-8 transcription Mastermind homolog in
Notch signaling
- ++ + -- -
skn-1 transcription bZIP - ++ ne - -
sknr-1 transcription bZIP - ++ + -- -
F54D5.11 transcription TFIIE beta subunit - ++ --- -
taf-1 transcription TBP-associated factor (bromodomain) - ne ++ -- - N o
1
taf-5 transcription TBP-associated factor (WD40 domain) - ++ + -- -
tlf-1 transcription TATA binding TFIID - + - --- +/2 Yes
let-526 transcription ARID/BRIGHT - ++ + + -w t N o
1
See Materials and Methods for a detailed description of scoring criteria. Abbreviations: ne, not embryonic lethal; wt, wildtype.
1possible reasons that the mutant phenotype did not recapitulate the RNAi phenotype include maternal rescue (of balanced lethals), non-null alleles, off-target effects
of the RNAi clone or synergy with the nre-1(-) lin-15b(-) background.
doi:10.1371/journal.pgen.1002109.t003
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15(ot86) mutants along with ectopic expression of the ceh-2 vulval
cell marker (data not shown). Through whole genome sequencing,
rescue, and analysis of deletion alleles provided by the C. elegans
knockout consortia, we find that lsy-15 indeed corresponds to rbbp-
5 (Figure 8, Table S3 and see below).
We analyzed several other members of the COMPASS complex
that were not revealed by our RNAi screen, using RNAi, mutant
alleles or both. We identified a SET-type methyltransferase
component, set-2 (a SET1A&B ortholog) and another two WD40
proteins, swd-3.1 and swd-2.2 (the WDR5 and WDR82 orthologs)
as having ASE laterality defects similar to those observed in rbbp-5,
dpy-30 and ash-2 mutants (Figure 7 and Table S3). The ASE
laterality defects of set-2 and swd-2 were only revealed in a
genetically sensitized lsy-6(ot150) background. Additionally, this
background enhanced the penetrance of the RNAi defects
observed in several other COMPASS complex components (Table
S3). Together we find that all core components of the COMPASS
complex regulate ASE laterality.
The COMPASS complex acts during embryogenesis and
upstream of the miRNA lsy-6 to regulate ASE laterality
To determine when and where COMPASS acts to regulate
ASE asymmetry we focused on rbbp-5 and generated several
reporter gene and rescue constructs. A GFP-tagged fosmid array
that fully rescues the ASE laterality defects of rbbp-5(ot86) mutants
is expressed ubiquitously during early embryogenesis and is
predominantly nuclear localized (Figure 8D–8E). We observe
similar expression of a translational reporter gene construct
containing the intergenic region upstream of rbbp-5 (data not
shown). This is consistent with previously reported broad
expression of several other components of the COMPASS
complex [31,32]. At later stages, during and after the birth of
the ASE neurons, rbbp-5 expression is significantly reduced
throughout the embryo. We are able to observe overlapping
expression with a reporter gene expressed bilaterally in the ASE
neurons, however, we note that expression of the transgenic array
in the ASE neurons was relatively infrequent despite the fact that
array carrying animals are fully rescued (Figure 8D–8E).
Additionally, we also observe complete rescue of the ASE laterality
defects in non-array carrying worms derived from array positive
mothers suggesting that the fosmid array can maternally rescue
rbbp-5(ot86) mutants. Consistent with this we observe maternal
germline expression of the rbbp-5 fosmid (Figure 8E) and the
mutants themselves are maternally rescued (data not shown).
These observations provide a hint that rbbp-5 and the COMPASS
complex may act early during embryogenesis to regulate ASE
asymmetry. To examine this possibility in more detail, we
attempted to rescue the rbbp-5 mutant phenotype by driving an
rbbp-5::gfp translational fusion using two heterologous promoters:
Table 4. Genes that elicit ASE asymmetry defects when knocked-down by RNAi.
Gene Name
Functional
Category Domain/Function ASEL ASER ASE Viable
RNAi ASE
phenotype
Mutant
phenotype
klp-16 cell/organelle Kinesin-like + wt wt Class IV (mixed) Yes
F21H12.1 chromatin Histone methyltransferase complex (WD40
domain)
++wt Yes Class II (2-ASER)
1 Yes
lin-49 chromatin Histone acetylltransferase complex
(bromodomain)
- + wt Yes Class II (2-ASER) Yes
ash-2 chromatin Histone methyltransferase complex (SPRY
domain)
++wt Class II (2-ASER)
1 Yes
dpy-30 chromatin Histone methyltransferase complex ++wt Class II (2-ASER)
1 Yes
uri-1 chromosome Prefoldin + - ne Class I (2-ASEL)
smk-1 chromosome Regulatory subunit of the protein
phosphatase 4
- +/2 +/2 Class II (2-ASER)
tac-1 chromosome Microtubule-based processes (TACC protein
family)
+ wt wt Class IV (mixed)
sams-3 metabolism S-adenosylmethionine synthetase + - wt Yes Class IV (mixed)
sams-4 metabolism S-adenosylmethionine synthetase + - wt Yes Class IV (mixed)
grp-1 signaling Guanine nucleotide exchange factor + wt wt Yes Class IV (mixed) Yes
smo-1 signaling SUMO - + wt Class II (2-ASER) Yes
C07A9.2 splicing G10 splicing factor family (BUD31 ortholog) + wt wt Class IV (mixed)
rsp-7 splicing SR protein family (RNA binding RRM domain) - +/2 +/2 Class II (2-ASER)
ddx-23 splicing U5 snRNP-like RNA helicase subunit (DEAD
and helicase)
- + wt Class II (2-ASER)
die-1 transcription C2H2 Zn finger transcription factor - + wt Class II (2-ASER) Yes
lsy-22 transcription Groucho-like + - +/2 Class I (2-ASEL) Yes
lsy-2 transcription C2H2 Zn finger transcription factor - + wt Yes Class II (2-ASER) Yes
fozi-1 transcription C2H2 Zn finger transcription factor + wt wt Class IV (mixed) Yes
lim-6 transcription LIM homeobox - + wt Yes Class II (2-ASER) Yes
See Materials and Methods for a detailed description of scoring criteria. Abbreviations: ne, not embryonic lethal; wt, wildtype.
1a low penetrant Class I (2-ASEL) phenotype was also observed.
doi:10.1371/journal.pgen.1002109.t004
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the mother of the ASE neurons and then in the mature ASE
neurons throughout the life of the animal or (2) the ubiquitous hsp-
16 heat-shock promoter. We find that ASE-specific expression of
rbbp-5 only minimally rescues the rbbp-5(tm3463) mutant pheno-
type, despite being strongly expressed in the ASE neurons as
expected (Figure 7B and Figure S6). In contrast, leaky expression
from lines carrying the hsp-16 construct and maintained at room
temperature strongly rescues the ASE laterality defect in a dose
dependent manner, despite rare expression in the post-mitotic
ASE neurons (Figure 7B and Figure S6). We next performed
staged heat-shocks using those lines with minimal rescue ability of
the rbbp-5 laterality defect at room temperature. We find that
when the heat-shock is performed early during embryogenesis,
before the birth of the ASE neurons, the ASE laterality defect is
fully rescued (Figure 7B). In contrast, if the heat-shock is
performed at or after the birth of the ASE neurons the defect is
only weakly rescued. We conclude that rbbp-5 acts before the
generation of the ASE neurons.
The most upstream component of the previously described
network of laterality factors is the ASEL-expressed miRNA lsy-6.
We find that lsy-6 expression is lost upon abrogation of various
COMPASS components (Figure 7C and Table S3). Moreover, the
‘‘2 ASEL’’ fate inducing activity of lsy-6, expressed from a
heterologous promoter, is epistatic to the loss of COMPASS
activity (rbbp-5 mutants), corroborating the notion that COMPASS
acts upstream of lsy-6 (Figure 7D and Table S3).
Previous genetic screens have revealed that a MYST-type
histone acetyltransferase (HAT) complex also shows ASE laterality
defects that are indistinguishable from those of the COMPASS
histone methyltransferase (HMT) complex, in that the ASEL
neurons convert into ASER neurons and that lsy-6 expression is
lost in the post-mitotic ASE neurons [33]. One of the components
of the MYST HAT complex was also retrieved from our RNAi
screen (the PHD/Bromodomain lin-49 locus). Given the pheno-
typic similarity between the MYST HAT and COMPASS HMT
complex, we asked whether they genetically interact. This
hypothesis was born out of biochemical studies that suggest that
histone methylation is often a prerequisite for ensuing histone
acetylation and transcriptional activation [34]. We tested for a
genetic interaction by asking for synergies in gene function. We
chose conditions in which RNAi against two different HMT
components (ash-2 and lsy-15) resulted in essentially no laterality
defect (in a non-sensitized, rather than nre-1; lin-15b RNAi
hypersensitive background) and tested the effect of RNAi against
these genes either in a wildtype background or in a MYST HAT
mutant background (the lsy-12 MYST-like HAT gene and the lsy-
13 ING-like gene). We observed strikingly synergistic phenotypes
in both lsy-12 and lsy-13 mutant backgrounds (Figure 7E). In
contrast, ash-2 RNAi was unable to enhance the defects of rbbp-5
mutants (Figure 7E) and only additive or mild synergy at best was
observed in ceh-36 mutants (Table S3). All together, this data
demonstrates that rbbp-5 and the COMPASS complex acts early
during embryogenesis, before the birth of the ASE neurons and in
conjunction with the MYST complex to regulate the expression of
the miRNA lsy-6 and therefore ASE laterality.
Discussion
We described here the first comprehensive, genome-wide RNAi
screen that monitors a single neuron-type cell fate decision. The
screen has been remarkably successful in retrieving genes known to
be involved in controlling ASE neuron specification. Six genes
previously known to be involved in ASE neuron specification have
been found in an unbiased manner (che-1, die-1, lsy-2, lin-49, lim-6,
fozi-1) and only two have not (cog-1, nhr-67: these genes also display
no laterality defects with sequence-verified RNAi clones). The
RNAi screen also revealed a number of genes that we would have
predicted to result in ASE lineage defects, including genes involved
in the segregation of early patterning cues (e.g. par and mex- genes)
and involved in a re-iteratively used binary fate decision system (lit-
1 gene)[7]. Moreover, the RNAi screen assisted the cloning of two
previously unknown lsy mutants, lsy-15/rbbp-5 (this paper) and lsy-
22 [35] by identifying genes with laterality defects in the genetic
intervals to which lsy-15 and lsy-22 had been mapped, facilitating
the identification of the phenotype-inducing mutation within the
whole-genome sequencing data.
The screen identified an as yet elusive proneural patterning
gene for the ASE lineage, the bHLH gene hlh-14. Previous forward
genetic screens for ASE differentiation mutants have failed to
retrieve alleles in this gene, possibly because these screens are
intrinsically biased against alleles in mutants with lethal pheno-
types, illustrating a key conceptual advantage of the RNAi
Table 5. hlh-14 is required for the ASE neurons and several
other neurons in the same lineage branch.
Phenotype
Genotype Loss Partial loss
1 Intact
hlh-14(RNAi); nre-1(hd20) lin-15b(hd126) 50% 6% 100%
hlh-14(tm295)/+ 0% 0% 100%
hlh-14(tm295) 97% 0% 3%
hlh-14(gm34)/+ 0% 0% 100%
hlh-14(gm34) 77% 0% 23%
hlh-14 (RNAi); nre-1(hd20) lin-15b(hd126) 7% 1% 92%
hlh-14(tm295)/+ 0% 0% 100%
hlh-14(tm295) 99% 0% 1%
hlh-14(gm34)/+ 0% 0% 100%
hlh-14(gm34) 88% 0% 12%
hlh-14(tm295) + Ex[hlh-14
FOS::gfp] #1 5% 0% 95%
hlh-14(tm295) + Ex[hlh-14
FOS::gfp] #2 4% 0% 96%
hlh-14(tm295) + Ex[hlh-14
FOS::gfp] #3 10% 0% 90%
hlh-14(tm295) + Ex[hlh-14
FOS::gfp] #4 2% 0% 98%
hlh-14 RNAi; nre-1(hd20) lin-15b(hd126) 4% 26% 70%
hlh-14(tm295)/+ 0% 3% 97%
hlh-14(tm295) 95% 5% 0%
hlh-14(tm295)/+ 0% 0% 100%
hlh-14(tm295) 60% 38% 2%
hlh-14(tm295)/+ 0% 0% 100%
hlh-14(tm295) 6% 29% 65%
Phenotypic characterization and rescue of hlh-14 mutants and hlh-14 RNAi. In all
cases n.40.
1Partial loss refers to a diming in the case of those markers that are
asymmetrically expressed and a loss of one cell for those makers bilaterally
expressed.
2Scored with lim-6::gfp(otIs114).
3Scored with gcy-5::gfp(otIs186); See Materials and Methods for fosmid array
details.
4Scored with che-1::gfp(otIs217) except for the RNAi which was scored with
8xASE::gfp(otIs299).
5Scored with ser-2
prom3::gfp(otIs138) or 8xASE::gfp(otIs299).
6Scored with gcy-8::gfp(oyIs17).
doi:10.1371/journal.pgen.1002109.t005
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PLoS Genetics | www.plosgenetics.org 12 June 2011 | Volume 7 | Issue 6 | e1002109Figure 5. The achaete-scute homolog hlh-14 is required to specify neurons in the ASE lineage. A: hlh-14 is required for the terminal
specification of several neuron pairs from the ABalppp/praaa lineage branch. Images of hlh-14(tm295) mutants indicating a loss of ASE (ASEL: lim-
6
prom::gfp, ASER: gcy-5
prom::gfp and ASEL/ASER: che-1
prom::rfp) OLL (ser-2
prom2:gfp) and AFD (gcy-8::gfp) cell fates. Heterozygous balanced siblings are
unaffected (presence of balancer indicated by GFP in the pharynx). B: Lineage, 3D-morphogenesis and hlh-14 expression analysis in the ABalppp/
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developmental defects have successfully retrieved hypomorphic
alleles of essential genes [18], in the case of hlh-14, alleles that
separate essential functions from its proneuronal function in the
ASE lineage may not exist. We have demonstrated that hlh-14 is
required for the production of neurons from several distinct
lineages. Besides lin-32/Atonal [36], hlh-14 is only the second
bHLH gene in C. elegans described with such a canonical neural
versus hypodermal switch function. It is possible that hlh-14 may
also regulate more general neural/non-neural decisions, such as
the ‘‘non-clonal’’ production of neurons from the multi-potent
pharyngeal lineages. Additionally, we have shown that the loss of
hlh-14 leads to neuronal sub-type differentiation defects, suggesting
that, in a similar fashion to lin-32 [37], it may act at multiple stages
of neuronal differentiation.
How hlh-14 is regulated remains to be discovered. Although
early pre-patterning mechanisms that regulate proneural gene
expression have been well described in both vertebrates and
Drosophila, few direct activators of proneural genes have been
identified [38,39]. In C. elegans, lin-32 is activated by Hox genes
and is also repressed by ref-1, a downstream effector of Notch
signaling [40,41]. This suggests parallels to the Notch-mediated
regulation of vertebrate proneural genes [39]. Intriguingly, an
ectopic ASE lineage is generated from the ABara blastomere in ref-
1 mutants [12] and it will be interesting to determine whether this
is due to a de-repression of hlh-14.
We observe L/R bilaterally symmetric expression of hlh-14 in
neuroblasts of symmetric origin but remarkably we also observe
L/R bilaterally symmetric expression of hlh-14 in lineages that
derive from asymmetric lineage origins. This expression is initiated
at an identical moment in time on both the left and right sides,
despite the neuroblasts deriving from L/R asymmetric origins and
is the case in both the ASEL/ASER lineages and the I1L/I1R
lineages. In both cases, expression coincides with the point at
which these lineages become bilaterally symmetric in that they
undergo an identical set of divisions to generate the left-right
homologs of bilateral pairs of neurons. Future identification of
upstream regulators of hlh-14 and other factors that are expressed
during this ‘‘symmetrization phase’’ will begin to address how left-
right bilateral symmetry is established in the nervous system.
Intriguingly, we also observe left/right asymmetric expression of
hlh-14, which is required to induce the fate of certain asymmetric
neuroblasts/neurons of the C-lineage. It will be interesting to
determine how this asymmetric expression is induced, how it is
coordinated with bilaterally symmetric expression programs and
whether, given the anterior-posterior lineage difference
(Figure 6C), asymmetric expression is regulated by the binary
Wnt-signaling system [7].
Given that hlh-14, like lin-32, fulfills its proneural function in
several very distinct neuronal lineages [28](this paper), it is obvious
that additional co-factors must exist to determine specificity of
bHLH gene action. With this thought in mind, we were surprised to
find essentially no other transcriptional regulator that is involved at
the neuronal versus ectodermal decision step - or any later or earlier
step in controlling the generation of the ASE lineage branch. This is
also surprising from the perspective of the binary, Wnt-mediated a/
p decision system that works broadly throughout the developing C.
elegans embryo [7,42,43]. Through mutant analysis we have
previously shown that this system also operates in the ASE lineage
[44] and, moreover, we have also identified in this screen the lit-1
gene, an important signal transducer of the binary system [43]. This
binary specification system, whose critical output is a differential
distribution of a POP-1/LEF transcription factor in dividing cells, is
generally thought of as needing to pair with lineage-specific
transcriptional regulators to instruct development [8,44]. In other
words, differentially distributed POP-1/LEF-1 is thought to interact
with cell-intrinsic transcriptional ‘‘codes’’ (i.e. combinations of
transcription factors) to define regulatory states that are character-
istic and specific for any cell at any stage of development. Since the
pop-1 system presumably cooperates with different transcription
factors at each of the a/p divisions that generate ASE, we expected
to reveal a wealth of transcriptional regulators. Even if such factors
had pleiotropic functions early in the embryo, our screen should
have nevertheless revealed them as non-gfp-positive, dead embryos.
Yet, with the exception of the known transcription factors (TFs) and
hlh-14, we identified no novel TF in the set of 801 TFs screened in
our RNAi library that affect ASE specification. Moreover, we noted
that only about 12% of TFs in the genome-wide TF clone library
resulted in the embryonic arrest phenotype that one would expect
from strong lineage patterningdefects.Inallthesearrestedembryos,
the ASE neurons are generated normally, with the exception of the
known embryonic patterning genes pie-1 and skn-1. Finally, 59 TFs
generated a P0 sterile phenotype preventing the analysis of F1
phenotypes in the nre-1 lin-15b background. We re-screened these
genes in wildtype and rrf-3 or eri-1; lin-15b RNAi hypersensitive
backgrounds, but uncovered no additional regulators of ASE fate
(data not shown).
There are several possible and non mutually-exclusive expla-
nations for the paucity of TF phenotypes. The simplest is a
technical one, RNAi may not sufficiently knock down specific TFs.
Supporting this notion, the cog-1 homeobox gene does not display
an ASE laterality defect by RNAi and was not retrieved by the
praaa lineage of wild-type (containing the ntIs1 transgene), hlh-14(gm34); otIs114, hlh-14(tm295); ntIs1 and hlh-14(tm295); otEx4507,E x [hlh-14
FOS::yfp];
ntIs1 embryos. The left panel shows the division pattern and expression (purple lines) of hlh-14 in the ABalppp/praaa lineage as determined by 4D-
lineage analysis. hlh-14 expression was assessed in both gmIs20 and hlh-14(tm295); Ex[hlh-14
FOS::yfp] animals. In wild-type embryos the cells divided as
expected. In hlh-14(gm34) mutants the 3 most posterior great-granddaughters of the ABalppp/praaa blastomere fail to divide. In hlh-14(tm295)
mutants these defects extend to the 4 most posterior granddaughter. The number of lineages that divided as indicated by the lineage and the total
number of individual left or right lineages followed to terminal division (and assessed for 3D cell positions) are shown at the bottom of each lineage
diagram. The asterisks indicate that on one occasion the lineages still divided but aberrantly, much later than normal. N indicates neurons and G
indicates glia. The right panel shows representative examples of the 3D-positions of cells from the ABalppp/ABpraaa lineage at the AB
256-cell stage as
assessed by 4D-lineage analysis. Both ventral and frontal views are presented. The posterior descendants of the ABalppp/praaa blastomere are
dorsally and posteriorly mispositioned in hlh-14 mutants (asterisks), a position normally occupied by hypodermal cells. The fosmid array rescues the
division and morphogenesis defects. The gut lineage is indicated for positional information. Cell coloring, except C-lineage, after [10]. The purple
triangle under the panel indicates that hlh-14 expression is lost more rapidly in the anterior of the lineage and this correlates with more penetrant
defects in posterior parts of lineage in hlh-14 mutants. C: Images of hlh-14 expression in embryos at the pre-morphogenesis (AB
256-cell) stage. Top
panel shows the expression of hlh-14 from an integrated translational hlh-14::gfp reporter [28]. Bottom panel shows the expression of hlh-14 from a
rescuing YFP-tagged hlh-14 fosmid array. Expression in the ASE, PVQ/HSN/PHB, and DVC/PVR lineages is indicated. The full expression pattern of hlh-
14 in the ABalppp/praaa lineage is indicated by purple lines in the lineage diagram in panel C and full expression in the C-lineage is indicated in
Figure 6.
doi:10.1371/journal.pgen.1002109.g005
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one is well exemplified with the T box TFs tbx-37 and tbx-38 [13].
We have previously shown that both are required at an early point
in the lineage that generates the ASEL neuron for the correct
establishment of ASE asymmetry [12]. Yet both genes act
redundantly; removal of either gene alone has no effect [13].
The C. elegans genome contains a good number of closely related,
paralogous TF pairs from various families and it is conceivable
that particularly during early patterning, TFs may work in
redundant pairs. In addition to the tbx-37/38 case, there are
several other reported cases for such redundant TF pairs (pes-1/
fkh-2 [45], med-1/med-2 [46]; end-1/end-3 [47] tbx-8/tbx-9 [48] and
ref-family genes [41]).
The early lineage determination of ASE left-right asymmetry
led us to postulate the existence of either an ‘‘asymmetry mark’’
that can be remembered through several rounds of division to
regulate expression of the miRNA lsy-6 expression or a cascade of
TFs that leads from tbx-37/38 to lsy-6 [12]. Previous work from
our lab has identified a MYST-type histone acetylase complex that
controls ASEL/R asymmetry through regulation of the lsy-6
miRNA [33] and in this study we have shown that the histone
methyltransferase complex COMPASS also regulates ASE
laterality through regulation of lsy-6 (Figure 7). We have shown
that COMPASS may be directly linked to the MYST HAT
complex activity, as supported by phenotypic similarity as well as
genetic interaction tests. Mechanistically, histone methylation may
be a step directly upstream of and preceding histone acetylation,
leading to transcriptional activation in several contexts (reviewed
in [49]). In the context of ASE asymmetry, this is supported by two
components of the MYST HAT complex containing a PHD
domain (the LIN-49 protein and the LSY-13 protein), which is
known to interact with methylated histones [34,50]. Indeed,
biochemical studies show that the PHD finger of lsy-13 ortholog
ING, recognizes the H3K4 trimethylation mark of COMPASS
and serves as a link in site specific recruitment of HATs [51,52].
Our synergistic data corroborate this idea in an in vivo context and
demonstrate that the COMPASS complex acts before the birth of
the ASE neurons, providing a potential molecular link between the
early Notch signal, the expression of tbx-37/38 and the ASEL
specific expression of lsy-6. Together, these histone-modifying
complexes may form part of a lineage-specific ‘‘chromatin mark’’
that acts, in cohort with specific TFs to bias lsy-6 expression, such
that it is only expressed in ASEL.
What other genes and processes has our screen revealed? Many
of the genes revealed in our RNAi screen as being involved in
neural development code for proteins with apparently very general
cellular functions, such as general splicing factors and core
components of RNA polymerases. The remarkably specific effects
of some of these factors suggest that some of these proteins may
not have as broad roles as previously thought or it may argue that
some of the substrates (e.g. those of splicing factors) relevant to
specific neuronal lineage decisions are sensitive to gene dosage
(and therefore more easy to functionally impair) than other, more
generally acting substrates. In addition, early C. elegans embryo-
genesis is characterized by very specific signaling events between
specific individual blastomeres [53]. Several of the genes that we
Figure 6. Asymmetric expression and function of hlh-14 in the
C-lineage. A: Ventral view of the 3D-positions of certain cells of the C-
lineage of a representative wild-type embryo at the AB
256-cell stage
(shortly after the division of the ASE grandmothers), as assessed by 4D-
lineage analysis. The left-sided asymmetric neuroblast Caapa and the
neuron PVR express hlh-14 (purple asterisks). Cells of the gut and the
ASE lineages are shown for positional information. Cell coloring, except
C-lineage, after [10]. B: Ventral view in both DIC and fluorescence of a
representative lineaged hlh-14(tm295); Ex[hlh-14
FOS::yfp]; ntIs1 embryo
at the AB
256-cell stage. C: Panel shows the expression (purple lines) of
hlh-14 and the division pattern of part of the C-lineage as determined
by 4D-lineage analysis of wild-type (containing the ntIs1 transgene, hlh-
14(gm34); otIs114, hlh-14(tm295); ntIs1 and hlh-14(tm295); otEx4507,
Ex[hlh-14
FOS::yfp]; ntIs1 embryos. hlh-14 expression was assessed in both
gmIs20 and hlh-14(tm295); Ex[hlh-14
FOS::yfp] animals. The Caapa
blastomere divides early in hlh-14 mutants, at a time when closely
related cells produce hypodermal cells. This defect is rescued by the
hlh-14
FOS::yfp transgene. The extra hyp11 cell that can be observed
expressing dpy-7 (Figure S3), is indicated. The number of lineages that
divided as indicated and the total number of individual left or right
lineages followed to terminal division are shown at the bottom of each
lineage diagram. Red cell names indicate neurons/glia and yellow cell
names indicate hypodermis.
doi:10.1371/journal.pgen.1002109.g006
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disrupting early blastomere divisions and positions resulting in
aberrant signaling events and lineage misspecifications. For yet
other genes - many of them with intriguing molecular identities -
their function in determining ASE remains to be determined and
will likely provide novel insights into the mechanisms of neural
specification.
Materials and Methods
Strains and transgenes
Strains and transgenes used. N2 Bristol wild type [1] and
CB4856 Hawaiian wild type [54]; OH2281, rrf-3(pk1426); otIs114;
him-5(e1490); OH7704, eri-1(mg366); lin-15b(n744); otis114; him-
5(e1490), and OH7082, nre-1(hd20) lin-15b(hd126); otis114; him-
5(e1490) [20]. VC1137, hda-1(ok1595) V/nT1[qIs51] (IV;V);
VC954, rnf-113(ok1401) III/hT2[bli-4(e937) let-?(q782) qIs48](I;III);
JK907, mog-4(q233)/mnC1 dpy-10(e128) unc-52(e444)II; VC2127,
mog-4(ok2708)/mT1 II; +/mT1[dpy-10(e128)] III; JK2321, mog-
5(q449) unc-4(e120)/mIn1[dpy-10(e128)] II; VC724, mog-5(ok1101)/
mIn1[mIs14 dpy-10(e128)] II; RB1593, klp-15(ok1505) I; RW3199,
lev-11(x12) let-49(st44)/lev-11(x12) unc054(e1152) I; VC186 smo-
1(ok359) I/szT1 [lon-2(e678) (I;X); NG2295, hlh-14(gm34)/mnC1
dpy-10(e128) unc-52(e444) II [28]; NG4280, hlh-14(tm295)/mIn1
[mIs14dpy-10(e128)]II [28]; RB979,F28B3.1(ok885) I; SM1017, tlf-
1(ok389)/unc-55(e402) dpy-24(s71) I; KR499, let-526(h185) dpy-
Figure 7. The evolutionary conserved methyltransferase COMPASS complex is required for ASE asymmetric cell fate specification.
A: Table and representative images of COMPASS complex indicating the ASE phenotype in multiple components of the COMPASS complex (for
detailed numbers see Figure S3). The image shown on the right is of the lsy-15(tm3463) mutant; all alleles of several members of the COMPASS
complex show an identical phenotype. The strain contains a reporter that marks ASEL (lim-6
prom::gfp) and a reporter that marks ASER (gcy-
5
prom::mcherry). The phenotype displayed is loss of ASEL (red circle) fate and a concomitant gain of ASER (blue circle) fate in ASEL. Asterisks denote
expression unrelated to ASE. B: Rescue of the rbbp-5 mutant phenotype with heterologous promoter lines (see Materials and Methods). ‘Early’ heat-
shocks were performed on embryos younger than the AB
256-cell stage, before the birth of ASE and ‘late’ heat-shocks on embryos older than the
AB
256-cell stage, after the birth of ASE. The che-1::rbbp-5::gfp construct was injected at 20 ng/ul and the hsp-16::rbbp-5::gfp construct was injected at
50, 20 and 2 ng/ul. Three lines of each were tested. Statistical significance (in comparison to the mutant alone unless otherwise indicated) was
assessed using a z-test and a Bonferroni correction was applied for multiple comparisons (*p,0.05, **p,0.01, ***p,0.001). The ASE phenotype was
scored with ASER marker gcy-5
prom::gfp (otIs220). In all cases n.30 except for the staged heat-shocks where n.8. C: Graphs indicating the left-right
ASE expression of lsy-6 in wild-type and COMPASS complex mutants. Ex[lsy-6::yfp] is an extrachromosomal array, otEx4410 Ex[lsy-6::yfp; ttx-3::mcherry].
Only array carrying worms were scored. In all cases n.50, see Table S3 for more detailed numbers. D: Graphs indicating the left-right ASE expression
of gcy-5
prom::gfp (ntIs1) in lsy-6 overexpressing, rbbp-5(tm3463) and double-mutant animals. Similar results were obtained with rbbp-5(ot86) (Table S3).
In all cases n.50. ASE::lsy-6 is ceh-36
prom::lsy-6 (otIs204). E: Graph indicating the percentage ASE defect following control (empty RNAi vector), ash-2
and rbbp-5 RNAi in wild-type, lsy-12(ot154), lsy-13(ok1475) and rbbp-5(tm3463) mutant animals. The ASE defect was scored with the ASEL marker lim-
6
prom::gfp (otIs114). Statistical significance (in comparison to control RNAi in relevant mutant background unless otherwise indicated) was assessed
using a z-test (*p,0.05, **p,0.01, ***p,0.001). In all cases n.70. Numbers for control (empty vector) RNAi are taken from Figure 1. For more
detailed numbers see Table S3. For the ASEL scoring of ash-2 and rbbp-5 RNAi in a wild-type background, RNAi was performed in both a strain
containing either the lim-6::gfp(otIs114) reporter to match the reporter present in lsy-12(ot154) strain and in a strain containing both the lim-
6::gfp(otIs114) and gcy-5::rfp(otIs220) reporter to match the lsy-13(ok1417) strain. No difference was observed and the numbers were pooled.
doi:10.1371/journal.pgen.1002109.g007
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4(e937) let-?(q782) qIs48] (I;III); RB1025, set-2(ok952) III; MT14851,
set-2(n4589) III; RB1304 swd-3.1(ok1417). dpy-30(y228) and dpy-
30(y130) III courtesy of B.J. Meyer. F21H12.1(tm3463) and
F21H12.1(tm3530) II, grp-1(tm1956) III, ash-2(tm1905) II, mag-
1(tm645) I: all obtained from Mitani Laboratory, NBP, Japan. lsy-
15(ot86) was isolated as previously described [18].
Transgenes to label ASEL and ASER fates. otIs3 V, Is[gcy-
7
prom::gfp; lin-15 (+)]; otIs114 I, Is[lim-6
prom::gfp; rol-6(d)]; otIs220 IV,
Is[gcy-5
prom::mCherry; rol-6(d)]; otIs186 Is[gcy-5
prom::gfp]; ntIs1 V,
Figure 8. The cloning and expression of lsy-15/rbbp-5(ot86). A: Protein schematic of LSY-15/RBBP-5 with the location and nature of mutant
alleles identified and/or used in this study. B: Schematic illustrating the SNP-mapping and genomic region of lsy-15/rbbp-5, and the fosmids used to
for expression and rescue analysis. lsy-15(ot86) was mapped to a ,15 MB interval on Chr II between the polymorphisms haw25186 and haw26022.
Two different fosmids were used to rescue lsy-15/rbbp-5(ot86) mutants, one of which was recombineered to express a translational lsy-15/rbbp-5::gfp
fusion for expression analysis. C: Whole genome sequencing (WGS) data for the lsy-15(ot86) allele. Only 4 protein coding variants resided in the
interval to which lsy-15(ot86) had been mapped, one of which was a premature stop in the rbbp-5 locus which was confirmed by Sanger sequencing.
1Variants were considered as background if they were also found in other WGS datasets from the lab (see Material and Methods). D: Rescue of the
rbbp-5 mutant phenotype with fosmid lines (see Materials and Methods). Statistical significance (in comparison to the mutant alone) was assessed
using a z-test and a Bonferroni correction was applied for multiple comparisons (*p,0.05, **p,0.01, ***p,0.001). E: Representative images of the
expression of the rbbp-5
FOS::gfp transgene. The top three images are in a lsy-15/rbbp-5(ot86) background and the bottom image is in a che-
1
prom::mcherry background that is expressed specifically in ASE neurons. Overlapping expression can be observed.
doi:10.1371/journal.pgen.1002109.g008
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prom::gfp; lin-15 (+)]; and the ASEL/ASER markers otIs151
V, Is[ceh-36
prom::DsRed2; rol-6(d)] and otIs232 V, Is[che-
1
prom::mCherry; rol-6(d)], otIs217 Is[che-1
prom::HIS-3::mCherry; rol-
6(d)] and otIs299 Is[8xASE::gfp; elt-2::dsRed].
Reporters for other cell types. OLL otIs138 Is[ser-
2
prom3::gfp; lin-15(+)] [55], AFD oyIs17 Is[gcy-8
prom::gfp; lin-15(+)]
[56]; muscle ccIs4251, Is[myo-3
prom::DFP-LacZ(NLS); myo-
3
prom::mitochondrial GFP; dpy-20(+)] [4]; gut (elt-2::gfp/LacZ)
(personal communication A. Grishok); dopaminergic and
cholinergic neurons otIs181, Is[dat-1
prom::mCherry; ttx-3
prom::mCherry]
[57]; hypodermis arIs99, Is[dpy-7
prom::2Xnls::yfp; ceh-22::gfp] [58];
pan-neuronal otIs287, Is[rab-3
prom::nls::yfp]; gmIs20 Is[hlh-14
prom::gfp]
[28].
Fosmid recombineering and transgenic arrays. Fosmids
were tagged as described [29] to generate OH10173-OH10176
otEx4507-otEx45010, Ex[hlh-14
FOS(WRM0627dH07)::yfp; rol-6(d)];
hlh-14(tm295); ntIs1 (4 independent lines); OH10171 otEx4506,
Ex[rbbp-5
FOS(WRM064bD12)::gfp; ttx-3
prom::mCherry]; otIs232.
Rescue of lsy-15(ot86): In addition to the tagged fosmid line
(above) the following untagged fosmid arrays were generated:
OH9335-OH9336, otEx4135-otEx4136 Ex[F21H12.1
FOS (WRM0
61bG10);elt-2::gfp] line 1 (2 independent lines).
Rescueoflsy-15(tm3463):Heterologouspromoterconstructswere
made by PCR fusion ([59]; primers available upon request) to
generate OH10177-OH10179 otEx4511-otEx4513, Ex[che-1
prom::
rbbp-5::gfp; elt-2
prom::gfp] (3 independent lines); OH10180-OH10182
otEx4514-otEx4516, Ex[hsp-16
prom::rbbp-5::gfp; elt-2
prom::gfp] (3 inde-
pendent lines; 50 ng/ul); OH10183-OH10185 otEx4517-otEx4519,
Ex[hsp-16
prom::rbbp-5::gfp; elt-2
prom::gfp] (3 independent lines; 20 ng/ul);
OH10186-OH10188 otEx4520-otEx4522,E x [ hsp-16
prom::rbbp-5::gfp;
elt-2
prom::gfp] (3 independent lines; 2 ng/ul).
Overexpression: OH7805 otIs204 Is[ceh-36
prom2::lsy-6, elt-
2
prom::gfp].
RNA interference
RNAi was performed using a bacterial feeding protocol [23] with
the following modifications. NGM agar plates containing 6 mM
IPTG and 100 mg/ml ampicillin were seeded with bacteria
expressing dsRNA. L4 staged hermaphrodites were placed onto
these plates and grown at 22uC. After five days, the F1 progeny of
these worms were scored for neuronal and pleiotropic defects. All
inserts of clones for the known ASE factors were sequenced to
confirm identity of the clone. The visible phenotypes screened for
chromosome I: Emb (embryonic lethal), P0 Ste (P0 sterile), Stp
(sterile progeny), Brd (low brood size), Gro (slow postembryonic
growth), Lva (larval arrest), Let (larval lethal), Adl (adult lethal), Bli
(blistering of cuticle), Bmd (body morphological defects), Clr (clear),
Dpy (dumpy), Egl (egg- laying defective), Lon (long), Mlt (molt
defects), Muv (multivulva), Prz (paralyzed), Pvl (protruding vulva),
Rol (roller), Rup (ruptured), Sck (sick) and Unc (uncoordinated).
Emb was defined as greater than 30% dead embryos. Each
phenotype was required to be present among at least 10% of the
analyzed worms for the visible pleiotropies and neuronal defects.
Non-viable (nonV) category encompasses P0 Ste, Emb, Stp and Let
phenotypes. The JA library of RNAi clones was purchased from
Geneservice (http://www.lifesciences.sourcebioscience.com/) and
was supplemented with the ORFeome based RNAi clones [60]
courtesy of John Kim [61]. Based on sequencing of several
randomly picked clones from the library we estimate the faithfulness
of the library to be 80–90% (data not shown).
Phenotypic scoring criteria
Primary screen. Primary screen was conducted by screening
two wells for the phenotypic categories ‘‘loss of ASEL’’ and ‘‘ectopic
ASEL’’. A positive clone was defined as having a phenotype in at
least 3/8 wells scored (or .=0.4). If clone had a phenotype (at least
one well), it was then re-screened an additional 6 times (see below).
An ASEL loss score was generated by dividing the number of wells
showing ‘‘loss of ASEL’’ over the total number of wells scored. An
ASEL ectopic score was generated by dividing the number of wells
showing ‘‘ectopic ASEL’’ over total number of wells scored. Thus,
in Tables 1, 2, 3, 4 and Tables S1 and S2 (see Results):
ASEL off (-) = ASEL off score .0, ASEL ectopic score 0;
ASEL ectopic (+) = ASEL ectopic score .0, ASEL off score 0;
ASEL mixed (+/2) = score in both ASEL off and ASEL
ectopic .0. For ASEL mixed category the following adjustment
was made: based on the ratio of (ASEL ectopic/ASEL off score) if
score ,=0.25 clones were moved to ASEL off. Based on ratio
(ASEL off/ASEL ectopic score) if score ,=0.25 clones were
moved to ASEL ectopic.
The ASE screen. The ASE screen was conducted by
screening 6 wells with an ASER specific reporter and bilateral
ASE reporter. Phenotypic scoring for ASER reporter consisted of
‘‘loss of ASER’’ and ‘‘ectopic ASER’’ while for bilateral ASE
reporter was ‘‘off’’, ‘‘1-on’’, ‘‘2-on’’, ‘‘ectopic ASEs’’ and ‘‘mixed’’
where ‘‘mixed’’ category was any combination of the above
phenotypes. The ASER phenotypic categorization was generated
in the same way as the ASEL above. Thus, in Tables 1, 2, 3, 4 and
Tables S1 and S2 (see Results):
ASER off (-) = ASER off score .0, ASER on score 0, .=1
wells screened;
ASEL ectopic (+) = ASER on score .0, ASER off score 0,
.=1 wells screened;
ASER mixed (+/2) = ASER off score .0, ASER ectopic score
.0, .=1 wells screened;
ASER wt = ASER score = 0, .=1 wells screened.
Blank means not done.
The ASE bilateral score was generated as follows:
ASE wt = ASE score = 0, .=1 wells screened;
ASE 2-off (-) = ASE 2-off score .0, all other scores 0, .=1
wells screened;
ASE 1-off (-) = ASE 1-off score .0, all other scores 0, .=1
wells screened;
ASE ectopic (+) = ASE ectopic score .0, all other scores 0,
.=1 wells screened;
ASE mixed (+/2) = ASE off scores (either of two) .0, ASE
ectopic score .0; or if scored .0 in the ASE ‘‘mixed’’, .=1 wells
screened.
The tissue marker screen. The tissue marker screen was
conducted by screening two wells, for phenotypic categories
‘‘tissue OFF’’ ‘‘tissue Mixed’’ ‘‘tissue ON’’, which were assigned an
arbitrary score of 0, 0.25 and 0.5 respectively. The final tissue
score of the clone was calculated by adding the individual scores of
the two wells, resulting in a range from minimum 0 (0+0) to
maximum 1 (0.5+0.5). If the score .0.5, the clone is ‘‘ON’’ for
that tissue; if the score is ,=0.5, the clone is designated ‘‘OFF’’.
In the Tables 1, 2, 3, 4 and Tables S1 and S2 (see Results Section)
‘‘ON’’ denoted ‘‘+’’, OFF denoted ‘‘2’’.
‘‘ne’’ means clone not embryonic lethal. Clones that were ‘‘ne’’
in 3 or more strains (out of 6 strains screened) were taken off the
list under the premise of non-repeatable embryonic phenotype.
Categorization in groups is described in Results.
Lineage and 3D cell position analysis of hlh-14 expression
and hlh-14 mutants
Cells were identified using 4D microscopy and SIMI BioCell
software as described in [10]. Briefly, wild-type (containing the
ntIs1 transgene), hlh-14:gfp (gmIs20), hlh-14(gm34); otIs114, hlh-
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FOS::YFP] gravid adults were
dissected and single two-cell embryos were mounted and
visualized on a Zeiss Axioplan 2 compound microscope. To
lineage hlh-14(tm295) mutants, non-array carrying embryos from
the hlh-14(tm295); ntIs1; otEx4507 Ex[hlh-14
FOS::YFP] strain were
examined. Nomarski stacks were taken every 35 seconds and
images within a stack at ,1 mm apart. Fluorescent images were
acquired at pre-determined time points during the course of
embryonic development. Movies were lineaged using the SIMI
BioCell program. The positions of cells at different time-points
were monitored using the 3D-feature of SIMI BioCell. All
additional DIC and fluorescent images were acquired using the
open source Micro-manager software [62].
Heat-shock rbbp-5 rescue experiments
Embryos were dissected from array carrying mothers, staged
and then subjected to a 15 minute heat-shock at 37uC after which
the embryos were placed at 15uC and allowed to develop to the L1
larval stage before scoring. Embryos were divided into two
categories for heat-shocks: ‘early’ = younger than AB
256-cell
stage; ‘late’ = older than AB
256-cell stage.
Mapping and whole-genome sequencing
The lsy-15(ot86) allele was mapped to a region of approximately
15 MB (Figure 6) through classic three-factor and single-
nucleotide polymorphism (SNP) mapping. Then, genomic DNA
was prepared from a population of lsy-15(ot86); otIs114 animals
using the Gentra GenePure DNA extraction kit. This genomic
DNA (5 mg) was genome sequenced as previously described [63]
using an Illumina Genome Analyzer II according to the
manufacturers specification. The resultant sequence data was
analyzed with MAQGene [64]. The following stringency criteria
were used to filter variants: quality score .=3, loci multiplicity
,=1, sequencing depth .=3. All detected sequence variants
were analyzed for whether they were present in any one of several
additional genomes of different genotypes that we sequenced in
the laboratory; if so, they were considered background and
eliminated from further analysis.
Supporting Information
Figure S1 Phenotypic classification in our screen for clones
previously reported to generate a Gro phenotype. Pie-chart that
illustrates the phenotype we observed in our screen for the 303
RNAi clones previously reported to generate a slow growing (Gro)
phenotype [22,23].
(EPS)
Figure S2 Only mex-3 and mex-5 generate pan-neuronal
differentiation defects. RNAi of those genes we identified in the
tissue screen as generating broad neuronal differentiation defects
in an non-sensitized strain carrying a pan-neuronal reporter (rab-
3::yfp). Indicated in each panel is the number of embryos that
showed a reduced number of rab-3 positive cells. In all cases only
those embryos that were lethal were examined, but we note that in
all cases the embryonic lethality was .50% and in most cases close
to 100%. No genes, other than mex-3 and mex-5 lead to a near
complete loss of all neurons. The paralogous G-protein regulators
gpr-1 and gpr-2 led to a mild but identifiable loss of many neurons
suggesting very broad defects, although the arrest stage of embryos
was somewhat variable. The phosphatase T09A5.9 led to a low
penetrant but identifiable loss of rab-3::yfp expression suggesting it
is the next broadest.
(EPS)
Figure S3 Ectopic expression of the dpy-7 hypodermal marker in
hlh-14(tm295) mutants. Expression of dpy-7::2Xnls::yfp can be easily
observed in ectopic hyp7 cells in the posterior of the embryo and
in an ectopic hyp11 cell (out of focus in the images). In the anterior
of the embryo ectopic or mispositioned hyp cells can be observed
(asterisks). Several embryos from an hlh-14(tm295)/mIn1 mother
were scored, defects were observed in approximately 25% of these
embryos as expected. The total number of embryos displaying the
defects is indicated beneath the figure.
(EPS)
Figure S4 Bilaterally symmetric expression of hlh-14 in other
neuronal lineages. A: Ventral view of the 3D-poitions of additional
bilaterally symmetric cells that express hlh-14 at the AB
256-cell
stage. In the posterior of the embryo neuroblasts from the
predominantly hypodermal ABplap/prap (green) and ABarpp
(pink) lineages express hlh-14. Cell coloring after [10]. B: Panel
shows the expression (purple lines) of hlh-14 and in certain cases
the division pattern as determined by 4D-lineage analysis of the
ABplap/prap lineages of wild-type embryos (containing the ntIs1
transgene). hlh-14 expression was assessed in both gmIs20 and hlh-
14(tm295); Ex[hlh-14
FOS::yfp] animals. In the case of the PLM/
ALN lineage, expression was only observed in gmIs20. Red cell
names indicate neurons/glia and yellow cell names indicate
hypodermis. C: Panel shows the expression (purple lines) of hlh-14
in the ABarpp lineage in wild-type embryos, as determined by 4D-
lineage analysis. Red cell names indicate neurons/glia and yellow
cell names indicate hypodermis.
(EPS)
Figure S5 Bilaterally symmetric expression and function of hlh-
14 in the I1L/I1R lineage. A: Ventral view of the 3D-poitions of
the bilaterally symmetric I1L/I1R neuroblasts (light blue) at the
AB
256-cell stage. The gut lineage is shown for positional
information. Cell coloring after [10]. B: Lineage and hlh-14
expression analysis of the I1L/I1R lineage in wildtype (containing
the ntIs1 transgene), hlh-14(tm295); ntIs1 and hlh-14(tm295);
otEx4507, Ex[hlh-14
FOS::yfp]; ntIs embryos. Purple lines indicate
the expression of hlh-14 (assessed in hlh-14(tm295); Ex[hlh-14
FOS::yfp
embryos) and the numbers below indicate the number of lineages
that divided as indicated and the total number of left or right
lineages followed to terminal division are shown at the bottom of
each lineage diagram indicate the total number of lineages
followed. The mother of the I1L/I1R blastomeres divides early in
hlh-14 mutants, at a time when sister lineage divides to produce
one pharyngeal marginal cell (mc1) and one pharyngeal muscle
cell (m3V). This defect is rescued with the hlh-14
FOS::yfp transgene.
Red cell names indicate neurons/glia and green cell names
indicate mesoderm.
(EPS)
Figure S6 Expression of che-1
prom::rbbp-5::gfp and hsp-16
prom::rbbp-
5::gfp transgenes. The che-1 promoter driven rbbp-5::gfp transla-
tional fusion is brightly expressed in ASE but does not rescue the
rbbp-5(tm3463) 2-ASER phenotype (see Figure 6). At room
temperature leaky expression of the heat-shock promoter driven
rbbp-5(tm3463)::gfp transgene can be observed in many cells, but
rarely in the ASE neurons, yet this rescues the rbbp-5(tm3463) 2-
ASER phenotype (see Figure 6).
(EPS)
Table S1 Genes that elicit a mixed ASE fate when knocked-
down by RNAi. See Materials and Methods for a detailed
description of scoring criteria. Abbreviations: ne, not embryonic
lethal; wt, wildtype.
(XLSX)
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when knocked-down by RNAi. See Materials and Methods for a
detailed description of scoring criteria. Abbreviations: ne, not
embryonic lethal; wt, wildtype.
(XLSX)
Table S3 COMPASS complex genes regulate ASE asymmetry
upstream of the microRNA lsy-6. Detailed scoring of COMPASS
complex component RNAi or mutant animals.
1ASEL fate scored
with lim-6::gfp(otIs114).
2ASER fate scored with *gcy-5
prom::gfp(n-
tIs1), **gcy-5
prom::rfp (otIs220) or ***gcy-5
prom::gfp(otIs186).
3Wildtype
phenotype for all three ASER reporter strains is 100% intact.
4Scored as young larvae.
5ASE::lsy-6 is ceh-36
prom::lsy-6 (otIs204).
6Ex[lsy-6::yfp] is an extrachromosomal array, otEx4410 Ex[lsy-
6::yfp; ttx-3::mcherry]. Only array carrying worms were scored.
7For
the ASEL scoring of ash-2 and rbbp-5 RNAi in a wildtype
backgroud, RNAi was performed in both a strain containing the
lim-6::gfp(otIs114) reporter to match the reporter present in lsy-
12(ot154) strain and in a strain containing both the lim-
6::gfp(otIs114) and gcy-5::rfp(otIs220) reporter to match the lsy-
13(ok1417) strain. No difference was observed and the numbers
were pooled.
(XLSX)
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